ConductScience.org, home

Paper41332151

Characterizing Apixaban Pharmacokinetics Through Physiologically-Based Pharmacokinetic Modeling: Critical Role of Biliary Secretion and Enterohepatic Circulation in Humans.

Tsuchitani T and 3 others. CPT Pharmacometrics Syst Pharmacol, 2026. Cited by 1 paper, by iCite.

Cite this record

ConductScience Library. Characterizing Apixaban Pharmacokinetics Through Physiologically-Based Pharmacokinetic Modeling: Critical Role of Biliary Secretion and Enterohepatic Circulation in Humans. Papers, record 41332151. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41332151

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Characterizing Apixaban Pharmacokinetics Through Physiologically-Based Pharmacokinetic Modeling: Critical Role of Biliary Secretion and Enterohepatic Circulation in Humans.
PubMed
Journal
CPT Pharmacometrics Syst Pharmacol
PubMed
Year
2026
PubMed
Publication types
Journal Article, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
1
iCite
Revised in PubMed
2026-10-23
PubMed

Authors4

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Tsuchitani TToshiakihttps://orcid.org/0000-0002-7257-3196
2Kou WWen
3Tomi MMasatoshi
4Sugiyama YYuichi

Source PubMed

Download CSV of authors

Topics14

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
PyridonesMajor topic
PyrazolesMajor topic
Models, BiologicalMajor topic
Factor Xa InhibitorsMajor topic
Enterohepatic CirculationMajor topic
BileMajor topic
Humans
Male
Adult
Administration, Oral
Female
Healthy Volunteers
Young Adult
Hepatobiliary Elimination

Source PubMed

Download CSV of topics

Grants1

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated by
Japan Science SocietyPubMed

Source PubMed

Download CSV of grants

References35

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
137991392Pharmacokinetics and pharmacodynamics of direct oral anticoagulants.Expert Opin Drug Metab Toxicol2023https://conductscience.org/library/papers/37991392PubMed
237101392Physiologically-based pharmacokinetic pharmacodynamic parent-metabolite model of edoxaban to predict drug-drug-disease interactions: M4 contribution.CPT Pharmacometrics Syst Pharmacol2023https://conductscience.org/library/papers/37101392PubMed
322759198Apixaban, an oral, direct factor Xa inhibitor: single dose safety, pharmacokinetics, pharmacodynamics and food effect in healthy subjects.Br J Clin Pharmacol2013https://conductscience.org/library/papers/22759198PubMed
433558262
Revisiting Nonlinear Bosentan Pharmacokinetics by Physiologically Based Pharmacokinetic Modeling: Target Binding, Albeit Not a Major Contributor to Nonlinearity, Can Offer Prediction of Target Occupancy.
Drug Metab Dispos2021https://conductscience.org/library/papers/33558262PubMed
528895074In Vitro Comparison of the Role of P-Glycoprotein and Breast Cancer Resistance Protein on Direct Oral Anticoagulants Disposition.Eur J Drug Metab Pharmacokinet2018https://conductscience.org/library/papers/28895074PubMed
633030266Physiologically-Based Pharmacokinetic Modeling for the Prediction of a Drug-Drug Interaction of Combined Effects on P-glycoprotein and Cytochrome P450 3A.CPT Pharmacometrics Syst Pharmacol2020https://conductscience.org/library/papers/33030266PubMed
734273071Perpetrator Characteristics of Azole Antifungal Drugs on Three Oral Factor Xa Inhibitors Administered as a Microdosed Cocktail.Clin Pharmacokinet2022https://conductscience.org/library/papers/34273071PubMed
839046333Clinical Implications of Co-administering Apixaban with Key Interacting Medications.Clin Pharmacol Drug Dev2024https://conductscience.org/library/papers/39046333PubMed
934095797Hepatic bile acid transport increases in the postprandial state: A functional 11C-CSar PET/CT study in healthy humans.JHEP Rep2021https://conductscience.org/library/papers/34095797PubMed
1038745377Elucidating nonlinear pharmacokinetics of telmisartan: Integration of target-mediated drug disposition and OATP1B3-mediated hepatic uptake in a physiologically based model.CPT Pharmacometrics Syst Pharmacol2024https://conductscience.org/library/papers/38745377PubMed
1137608051Induction of open-form bile canaliculus formation by hepatocytes for evaluation of biliary drug excretion.Commun Biol2023https://conductscience.org/library/papers/37608051PubMed
1228456723Hepatobiliary Clearance Prediction: Species Scaling From Monkey, Dog, and Rat, and In Vitro-In Vivo Extrapolation of Sandwich-Cultured Human Hepatocytes Using 17 Drugs.J Pharm Sci2017https://conductscience.org/library/papers/28456723PubMed
1318832478Apixaban metabolism and pharmacokinetics after oral administration to humans.Drug Metab Dispos2009https://conductscience.org/library/papers/18832478PubMed
1429453492Application of physiologically based pharmacokinetic modeling to the prediction of drug-drug and drug-disease interactions for rivaroxaban.Eur J Clin Pharmacol2018https://conductscience.org/library/papers/29453492PubMed
1516782767Use of cryopreserved human hepatocytes in sandwich culture to measure hepatobiliary transport.Drug Metab Dispos2006https://conductscience.org/library/papers/16782767PubMed
1631219028The Use of Activated Charcoal to Treat Intoxications.Dtsch Arztebl Int2019https://conductscience.org/library/papers/31219028PubMed
1717125407Species differences between mouse, rat, dog, monkey and human CYP-mediated drug metabolism, inhibition and induction.Expert Opin Drug Metab Toxicol2006https://conductscience.org/library/papers/17125407PubMed
1824277644Effect of activated charcoal on apixaban pharmacokinetics in healthy subjects.Am J Cardiovasc Drugs2014https://conductscience.org/library/papers/24277644PubMed
1931506301Systematic Development and Verification of a Physiologically Based Pharmacokinetic Model of Rivaroxaban.Drug Metab Dispos2019https://conductscience.org/library/papers/31506301PubMed
2037853850Cluster Gauss-Newton method for a quick approximation of profile likelihood: With application to physiologically-based pharmacokinetic models.CPT Pharmacometrics Syst Pharmacol2024https://conductscience.org/library/papers/37853850PubMed

See all 35 referencesDownload CSV of references

Cited by1

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 1 citation.

PMIDTitleJournalYearIn Papers
41332151Characterizing Apixaban Pharmacokinetics Through Physiologically-Based Pharmacokinetic Modeling: Critical Role of Biliary Secretion and Enterohepatic Circulation in Humans.CPT Pharmacometrics Syst Pharmacol2026https://conductscience.org/library/papers/41332151

Source PubMed

Download CSV of cited by

Genes1

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn Genes
F102159PubTator's text mininghttps://conductscience.org/library/genes/2159

Source NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/41332151

GET https://conductscience.org/api/papers/v1/41332151/references?page=2